Peer Review reports
From: Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis
| Original Submission | ||
|---|---|---|
| 19 Feb 2022 | Submitted | Original manuscript |
| 22 Mar 2022 | Reviewed | Reviewer Report |
| 24 Mar 2022 | Reviewed | Reviewer Report - Jianwei Xuan |
| 30 Mar 2022 | Author responded | Author comments - Jefferson Antonio Buendía |
| 12 Apr 2022 | Reviewed | Reviewer Report |
| 7 May 2022 | Reviewed | Reviewer Report |
| 18 May 2022 | Author responded | Author comments - Jefferson Antonio Buendía |
| Resubmission - Version 2 | ||
| 30 Mar 2022 | Submitted | Manuscript version 2 |
| 20 May 2022 | Author responded | Author comments - Jefferson Antonio Buendía |
| Resubmission - Version 3 | ||
| 20 May 2022 | Submitted | Manuscript version 3 |
| 25 May 2022 | Author responded | Author comments - Jefferson Antonio Buendía |
| Resubmission - Version 4 | ||
| 25 May 2022 | Submitted | Manuscript version 4 |
| Publishing | ||
| 27 May 2022 | Editorially accepted | |
| 23 Jun 2022 | Article published | 10.1186/s12890-022-02029-4 |
You can find further information about peer review here.